We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Investigational Drug for Melanoma Shows Promise in Early-Stage Study

News   Feb 23, 2018 | Original story from University of North Carolina Lineberger

 
Investigational Drug for Melanoma Shows Promise in Early-Stage Study

Effect of MK-8353 on pERK protein levels in normal epidermis in the MK-8353-001 study. Credit: doi:10.1172/jci.insight.92352.

 
 
 

RELATED ARTICLES

Zika Vaccine Shows Promise For Treating Deadly Brain Cancer

News

A Zika vaccine candidate has shown promise as a treatment for the deadliest type of brain cancer.

READ MORE

A Way to Enhance Adsorption of Chemotherapy Drugs

News

A new study demonstrates adsorption of chemotherapy drugs onto active carbon delivery capsule can be enhanced with aluminium atom inclusions.

READ MORE

Colon Cancer Fueled by Bacteria and Cell Stress

News

New research reveals that cell stress in combination with an altered microbiota in the colon drives tumor growth. Previously, it was assumed that this combination only contributes to inflammatory intestinal diseases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE